Trial Profile
Course of partial virological response to entecavir under long-term entecavir therapy and effect of switching to tenofovir disoproxil fumarate in patients with chronic hepatitis B virus infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 31 Aug 2015 New trial record